Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypospadias | 3 | 2022 | 77 | 2.110 |
Why?
|
| Genome-Wide Association Study | 28 | 2023 | 2265 | 1.800 |
Why?
|
| Cancer Survivors | 4 | 2022 | 650 | 1.240 |
Why?
|
| Blood Pressure | 11 | 2021 | 1467 | 1.230 |
Why?
|
| DNA Methylation | 6 | 2022 | 2669 | 1.050 |
Why?
|
| Genetic Loci | 9 | 2021 | 481 | 0.920 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2023 | 64 | 0.880 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2021 | 4549 | 0.830 |
Why?
|
| Heart Defects, Congenital | 2 | 2022 | 1697 | 0.760 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2020 | 20 | 0.760 |
Why?
|
| Rhabdomyosarcoma | 1 | 2023 | 341 | 0.710 |
Why?
|
| Telomere-Binding Proteins | 1 | 2020 | 85 | 0.700 |
Why?
|
| Diacylglycerol Kinase | 1 | 2019 | 23 | 0.690 |
Why?
|
| Lipids | 5 | 2020 | 644 | 0.660 |
Why?
|
| Cranial Irradiation | 1 | 2020 | 315 | 0.650 |
Why?
|
| Tetraspanins | 1 | 2017 | 42 | 0.620 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 677 | 0.550 |
Why?
|
| Hypertension | 6 | 2021 | 1503 | 0.540 |
Why?
|
| Genetic Variation | 6 | 2020 | 2086 | 0.520 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 610 | 0.520 |
Why?
|
| Neoplasms, Second Primary | 2 | 2021 | 1350 | 0.510 |
Why?
|
| Gene-Environment Interaction | 4 | 2020 | 166 | 0.500 |
Why?
|
| CpG Islands | 4 | 2020 | 633 | 0.480 |
Why?
|
| Lymphoma | 1 | 2022 | 1467 | 0.470 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1054 | 0.470 |
Why?
|
| Body Mass Index | 2 | 2020 | 2203 | 0.470 |
Why?
|
| Thyroid Neoplasms | 2 | 2021 | 1866 | 0.430 |
Why?
|
| Genotype | 10 | 2020 | 4109 | 0.420 |
Why?
|
| Alcohol Drinking | 3 | 2020 | 551 | 0.410 |
Why?
|
| Gene Frequency | 5 | 2020 | 1163 | 0.390 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 1491 | 0.390 |
Why?
|
| Quantitative Trait Loci | 4 | 2019 | 374 | 0.360 |
Why?
|
| Smoking | 4 | 2019 | 2440 | 0.330 |
Why?
|
| Risk Factors | 7 | 2022 | 17523 | 0.320 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 5159 | 0.320 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2023 | 502 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2023 | 5539 | 0.320 |
Why?
|
| Case-Control Studies | 4 | 2022 | 6100 | 0.310 |
Why?
|
| Obesity | 1 | 2020 | 2884 | 0.310 |
Why?
|
| Exome | 4 | 2017 | 1239 | 0.310 |
Why?
|
| Neoplasms | 3 | 2022 | 15193 | 0.300 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 2796 | 0.290 |
Why?
|
| Child | 9 | 2023 | 29154 | 0.290 |
Why?
|
| Genetic Pleiotropy | 2 | 2016 | 29 | 0.290 |
Why?
|
| Cohort Studies | 9 | 2022 | 9244 | 0.280 |
Why?
|
| Humans | 41 | 2023 | 261506 | 0.260 |
Why?
|
| Postoperative Complications | 1 | 2020 | 5542 | 0.260 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 1399 | 0.240 |
Why?
|
| Mediator Complex | 1 | 2023 | 69 | 0.220 |
Why?
|
| Male | 24 | 2023 | 123000 | 0.220 |
Why?
|
| Proportional Hazards Models | 2 | 2023 | 4988 | 0.220 |
Why?
|
| Leukemia | 2 | 2022 | 1635 | 0.220 |
Why?
|
| Infant | 4 | 2022 | 13310 | 0.210 |
Why?
|
| Female | 24 | 2023 | 141928 | 0.210 |
Why?
|
| Craniospinal Irradiation | 1 | 2023 | 128 | 0.210 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2022 | 100 | 0.200 |
Why?
|
| Telomere Shortening | 1 | 2021 | 56 | 0.200 |
Why?
|
| Pregnancy | 3 | 2022 | 7573 | 0.190 |
Why?
|
| Germ Cells | 1 | 2023 | 335 | 0.190 |
Why?
|
| Infertility | 1 | 2022 | 123 | 0.190 |
Why?
|
| Essential Hypertension | 1 | 2020 | 8 | 0.190 |
Why?
|
| Incidence | 2 | 2021 | 5673 | 0.180 |
Why?
|
| Dried Blood Spot Testing | 1 | 2020 | 21 | 0.180 |
Why?
|
| DNA Helicases | 1 | 2022 | 434 | 0.180 |
Why?
|
| Sleep | 2 | 2021 | 413 | 0.180 |
Why?
|
| Telomere Homeostasis | 1 | 2020 | 73 | 0.180 |
Why?
|
| Cluster Analysis | 1 | 2022 | 1053 | 0.180 |
Why?
|
| Arkansas | 1 | 2019 | 58 | 0.170 |
Why?
|
| Tuberous Sclerosis | 1 | 2020 | 136 | 0.170 |
Why?
|
| Arterial Pressure | 1 | 2019 | 107 | 0.170 |
Why?
|
| Adiposity | 1 | 2020 | 237 | 0.170 |
Why?
|
| Introns | 1 | 2020 | 432 | 0.160 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 148 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 333 | 0.160 |
Why?
|
| Neonatal Screening | 1 | 2020 | 165 | 0.160 |
Why?
|
| Clusterin | 1 | 2018 | 28 | 0.160 |
Why?
|
| Young Adult | 10 | 2020 | 21445 | 0.160 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1945 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 854 | 0.160 |
Why?
|
| Metagenomics | 1 | 2018 | 115 | 0.160 |
Why?
|
| Women's Health | 1 | 2019 | 205 | 0.150 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 434 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 246 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2020 | 2316 | 0.150 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 100 | 0.150 |
Why?
|
| Phylogeny | 1 | 2019 | 826 | 0.150 |
Why?
|
| Adolescent | 11 | 2021 | 31252 | 0.150 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 71 | 0.150 |
Why?
|
| Chromosome Mapping | 2 | 2019 | 1471 | 0.150 |
Why?
|
| Medulloblastoma | 1 | 2022 | 540 | 0.150 |
Why?
|
| Minority Groups | 1 | 2019 | 322 | 0.150 |
Why?
|
| Erythropoiesis | 1 | 2016 | 74 | 0.140 |
Why?
|
| Immune System Diseases | 1 | 2016 | 65 | 0.140 |
Why?
|
| Long QT Syndrome | 1 | 2016 | 92 | 0.130 |
Why?
|
| Heart Conduction System | 1 | 2016 | 165 | 0.130 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 203 | 0.130 |
Why?
|
| Adult | 12 | 2021 | 77950 | 0.130 |
Why?
|
| Erythrocytes | 1 | 2016 | 339 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 527 | 0.130 |
Why?
|
| Genome, Human | 2 | 2020 | 1869 | 0.120 |
Why?
|
| Prevalence | 1 | 2022 | 3260 | 0.120 |
Why?
|
| Leukocytes | 1 | 2016 | 422 | 0.120 |
Why?
|
| Cholesterol, HDL | 3 | 2020 | 341 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 1450 | 0.120 |
Why?
|
| Linkage Disequilibrium | 3 | 2019 | 460 | 0.110 |
Why?
|
| Triglycerides | 3 | 2020 | 603 | 0.110 |
Why?
|
| Epilepsy | 1 | 2020 | 883 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2022 | 8223 | 0.110 |
Why?
|
| Middle Aged | 13 | 2021 | 86204 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 2864 | 0.100 |
Why?
|
| DNA | 1 | 2020 | 2693 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2017 | 717 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2016 | 731 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 1183 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2022 | 37905 | 0.090 |
Why?
|
| Aged | 10 | 2020 | 70117 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 855 | 0.090 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 2195 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4053 | 0.080 |
Why?
|
| Epistasis, Genetic | 2 | 2020 | 119 | 0.080 |
Why?
|
| Antiporters | 2 | 2019 | 71 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 4314 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2020 | 16273 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 4849 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2017 | 4078 | 0.070 |
Why?
|
| Biomarkers | 1 | 2018 | 5047 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2020 | 12873 | 0.070 |
Why?
|
| Life Style | 2 | 2019 | 612 | 0.070 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 29902 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 565 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2017 | 2947 | 0.060 |
Why?
|
| Intelligence | 1 | 2023 | 126 | 0.060 |
Why?
|
| Phenotype | 3 | 2019 | 6295 | 0.050 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2022 | 101 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 7702 | 0.050 |
Why?
|
| GATA5 Transcription Factor | 1 | 2020 | 4 | 0.050 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 11 | 0.050 |
Why?
|
| Twin Studies as Topic | 1 | 2020 | 17 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2020 | 69 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2020 | 99 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 22 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 10 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2017 | 2218 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 221 | 0.040 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2019 | 95 | 0.040 |
Why?
|
| Carbon-Carbon Lyases | 1 | 2018 | 3 | 0.040 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2018 | 8 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2019 | 189 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 165 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2019 | 2819 | 0.040 |
Why?
|
| Health Equity | 1 | 2019 | 43 | 0.040 |
Why?
|
| Genetics, Medical | 1 | 2019 | 143 | 0.040 |
Why?
|
| Body Height | 1 | 2019 | 231 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2017 | 25 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2020 | 299 | 0.040 |
Why?
|
| Systole | 1 | 2018 | 196 | 0.040 |
Why?
|
| Diastole | 1 | 2018 | 187 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 101 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 1183 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2016 | 73 | 0.040 |
Why?
|
| Mean Platelet Volume | 1 | 2016 | 5 | 0.040 |
Why?
|
| Erythrocyte Indices | 1 | 2016 | 24 | 0.040 |
Why?
|
| Survivors | 1 | 2022 | 1031 | 0.040 |
Why?
|
| Allelic Imbalance | 1 | 2016 | 41 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 545 | 0.030 |
Why?
|
| Hematocrit | 1 | 2016 | 142 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 225 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 291 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2017 | 208 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2017 | 343 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 534 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 658 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 483 | 0.030 |
Why?
|
| Platelet Count | 1 | 2016 | 490 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 549 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 457 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2018 | 747 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 487 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 1489 | 0.030 |
Why?
|
| Exosomes | 1 | 2017 | 253 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2021 | 1824 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2016 | 477 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 1890 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 3441 | 0.030 |
Why?
|
| Family | 1 | 2016 | 736 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 986 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 3570 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 4892 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 1823 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2016 | 1145 | 0.020 |
Why?
|
| United States | 2 | 2019 | 15433 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 1678 | 0.020 |
Why?
|
| Stem Cells | 1 | 2017 | 1213 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2054 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5687 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 3869 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2020 | 6869 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6009 | 0.020 |
Why?
|
| Lung | 1 | 2017 | 3151 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2019 | 5270 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 7226 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 15179 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 11965 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 34495 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 59536 | 0.010 |
Why?
|